Stock Detail
COVANCE INC
Sector: Diversified Services
Latest Quote @ Sat May 5 07:44:40 (15 min delayed)
| N/A |
N/A |
$76.67 |
+0.15 |
0.20% |
|
Last Day's Data
| $76.67 |
$76.99 |
$0.15 |
0.20% |
0.00 |
$76.52 |
| $76.22 |
$75.42 |
196,751.00 |
4.28B |
407,426.00 |
39.78 |
Pivot Table
| R2 |
R1 |
Pivot |
S1 |
S2 |
| 77.93 |
77.30 |
76.36 |
75.73 |
74.79 |
Stock Profile
Covance, Inc. operates as a drug development services company. It offers a range of early stage and late stage product development services primarily to the pharmaceutical, biotechnology, and medical device industries worldwide. The company also offers laboratory testing services to the chemical, agrochemical, and food industries. Covance offers a range of early development services, including preclinical and Phase I clinical service offerings that involve toxicology services, pharmaceutical chemistry, and bioanalytical and related services. Its late-stage development services include central laboratory services, clinical development services, periapproval services, central electrocardiogram diagnostic services, and healthcare economic and reimbursement services. Covance was founded in 1987 and is headquartered in Princeton, New Jersey.
